Creative Biomart Blog

Tue, 2026/06/16

There Is No Safe Level of Alcohol Consumption: Even One Sip May Increase the Risk of Cancer and Other Diseases

The study shows that alcohol consumption is associated with an increased risk of breast cancer, colorectal cancer, esophageal cancer, laryngeal cancer, cancers of the lip and oral cavity, pharyngeal cancer, liver cancer, stomach cancer, pancreatic cancer, and prostate cancer. It is also linked to higher risks of pancreatitis, cirrhosis and other chronic liver diseases, lower respiratory tract infections, tuberculosis, and atrial fibrillation. The Complex Relationship Between Alcohol and Health The relationship between alcohol consumption and health is highly complex. Evidence on the links betw

Tue, 2026/06/16

Semaglutide May Slow Epigenetic Aging in Humans

Drugs originally developed to treat diabetes and obesity may have even more untapped health potential. As new generations of GLP-1 drugs continue to emerge, researchers will have opportunities to compare how different molecules affect aging regulation and to identify the groups of people most likely to benefit from such therapies. In recent years, GLP-1 receptor agonists represented by semaglutide have attracted widespread attention because of their significant weight-loss effects and glucose-lowering capacity. These drugs can also reduce the risk of cardiovascular disease and have become star

Tue, 2026/06/16

Removing the “Brake” CKAP4 in Macrophages May Restart the Healing Program

CKAP4 is a negative regulator of macrophage mechanosensing. Targeting CKAP4-related mechanotransduction pathways may offer a new mechanotherapeutic strategy for chronic wounds. The Challenge: Chronic Wounds Stuck in Inflammation Wound healing requires a timely transition from the inflammatory phase to the proliferative phase, whereas chronic wounds often remain stalled in the inflammatory stage for prolonged periods. How physical signals in injured tissues regulate macrophages and mediate this phase transition has remained unclear. A research paper titled “Targeting the macrophage mechan

Tue, 2026/06/16

Microenvironmental Protein CTHRC1 Shown to Promote Colorectal Cancer Progression

Researchers from the Center for Molecular Medicine at MaineHealth Institute for Research, the University of Maine, and other institutions have found that a protein called CTHRC1 acts as an “accomplice” in the microenvironment of colorectal cancer. The Tumor Microenvironment: More Than a Passive Bystander Colorectal cancer is one of the most common and deadliest digestive system malignancies worldwide. According to statistics from the International Agency for Research on Cancer of the World Health Organization, more than 1.9 million new cases of colorectal cancer and over 900,000 re

Tue, 2026/06/16

IL-4 May Help “Rejuvenate” the Aging Hematopoietic System

The study shows that activation of the IL-4–FLT3–STAT6 signaling axis in multipotent progenitors, or MPPs, can restore lymphocyte production under conditions of inflammation and aging. Aging, Inflammation, and Hematopoietic Imbalance Chronic inflammation and aging disrupt hematopoietic balance, driving a process known as myeloid skewing. In this state, hematopoietic stem and progenitor cells, or HSPCs, preferentially generate myeloid cells, while the production of lymphoid cells is suppressed. This imbalance can create a self-reinforcing cycle. Expanded myeloid cells continue to se

Tue, 2026/06/16

FGF21 Activates the Cell’s “Cleanup” System to Reverse Aging and Enhance Therapeutic Efficacy

The study shows that FGF21 can partially upregulate TFE3-mediated autophagy flux through the FGFR1–SIRT1–MTOR signaling pathway. This restores the vitality of adipose-derived mesenchymal stem cells, or ASCs, enhances their potential to differentiate into neural stem cells, and ultimately improves the therapeutic efficacy of ASC transplantation for acute intracerebral hemorrhage. Intracerebral Hemorrhage and the Need for New Therapies Intracerebral hemorrhage, or ICH, is a neurological disease characterized by high mortality, and there is currently no definitive cure. Studies have s

Tue, 2026/06/16

Can Lifespan Be “Read Out”?

-Nature Builds a Cross-Species Transcriptomic Clock to Predict Aging and Mortality Risk This study not only systematically maps a conserved molecular blueprint of aging and reveals its modular, decomposable nature, but also provides a powerful tool for aging research. Aging, Lifespan, and the Search for Molecular Clues Aging is accompanied by functional decline and an increased risk of death. Although diet, drugs, and genes are known to regulate lifespan, the shared molecular mechanisms behind these effects have remained something of a “black box.” At the same time, accurate biomar

Tue, 2026/06/16

Anticancer Antibodies Enter Tumors but “Lose Their Way”: A New Platform Identifies Physical Barriers in the Tumor Microenvironment

This study is the first to visually reveal, at single-cell resolution in human solid tumor tissues, the “spatial confrontation” between therapeutic antibodies and the tumor microenvironment. Antibody Drugs and the Challenge of Solid Tumor Treatment Antibody drugs are regarded as important weapons in precision cancer therapy. These drugs can specifically recognize targets on the surface of tumor cells and, in theory, achieve a form of “precision strike.” However, in clinical practice, many antibody drugs have shown far less efficacy against solid tumors than expected. He